Court declines to block drug ruling in patent case
moreView todays social media effects on MNTAView the latest stocks trending across Twitter. Click to view dashboardSee who Momenta is hiring next, click here to view […]
MNTA
U.S. top court denies Teva stay in Copaxone patent fight
moreView todays social media effects on MNTAView the latest stocks trending across Twitter. Click to view dashboardSee who Momenta is hiring next, click here to view […]
4:10 pm Momenta Pharma: S.A.C. Capital discloses 5.6% passive stake in 13G filing
moreView todays social media effects on MNTAView the latest stocks trending across Twitter. Click to view dashboardSee who Momenta is hiring next, click here to view […]
MOMENTA PHARMACEUTICALS INC Files SEC form 10-K, Annual Report
moreView todays social media effects on MNTAView the latest stocks trending across Twitter. Click to view dashboardSee who Momenta is hiring next, click here to view […]
Momenta Pharmaceuticals to Webcast Presentation at the Cowen and Company 34th Annual Health Care Conference
[GlobeNewswire] – CAMBRIDGE, Mass. — Momenta Pharmaceuticals, Inc. , a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that its presentation at the Cowen and … moreView todays social media effects on MNTAView the latest stocks trending across Twitter. Click to view dashboardSee who Momenta is hiring next, click here to view […]
MOMENTA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E
moreView todays social media effects on MNTAView the latest stocks trending across Twitter. Click to view dashboardSee who Momenta is hiring next, click here to view […]
Momenta Reports Wider Loss, Beats on Revenues
moreView todays social media effects on MNTAView the latest stocks trending across Twitter. Click to view dashboardSee who Momenta is hiring next, click here to view […]
Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2012 Financial Results
[at noodls] – CAMBRIDGE, Mass., Feb. 15, 2013 (GLOBE NEWSWIRE) — Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today reported its financial results for the fourth quarter and year ended December 31, 2012….This is an … moreView todays social media effects on MNTAView the latest stocks trending across Twitter. Click to view dashboardSee who Momenta is hiring next, click here to view […]
Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2012 Financial Results Conference Call and Webcast
[at noodls] – CAMBRIDGE, Mass., Jan. 24, 2013 (GLOBE NEWSWIRE) — Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will release … moreView todays social media effects on MNTAView the latest stocks trending across Twitter. Click to view dashboardSee who Momenta is hiring next, click here to view […]
Momenta Pharmaceuticals to Present at the Deutsche Bank 2012 dbAccess BioFEST
[at noodls] – CAMBRIDGE, Mass., Nov. 27, 2012 (GLOBE NEWSWIRE) — Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced … moreView todays social media effects on MNTAView the latest stocks trending across Twitter. Click to view dashboard […]
